Drug profile · INN
icodextrin
EXTRANEAL
icodextrin (EXTRANEAL) is a osmotic agent. Route of administration: intraperitoneal. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — icodextrin
- US status
- approved
- Class
- —
- Route
- INTRAPERITONEAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
icodextrin (EXTRANEAL) is a osmotic agent. Route of administration: intraperitoneal. Current US regulatory status: approved.
Key facts
INN icodextrin
Brand EXTRANEAL
Mechanism Osmotic agent
Route INTRAPERITONEAL
Formulation SOLUTION
Mechanism of action
Osmotic agent
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is icodextrin?
icodextrin (EXTRANEAL) is a osmotic agent. Route of administration: intraperitoneal. Current US regulatory status: approved.
What is the brand name for icodextrin?
EXTRANEAL is a marketed brand name for icodextrin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of icodextrin?
icodextrin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.